Options Brief: Geron Corporation

Shares of Geron Corporation GERN are lower on the session by 3.11%, trading at $4.36. Overall call volume is now running at 2.76x the daily average, with 70% of all calls traded being purchases on the offer. 3,096 contracts have traded on the session so far. Geron Corporation is a biopharmaceutical company that is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes.